Viridian Therapeutics, Inc. VRDN Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s total current assets?
- Viridian Therapeutics, Inc. (VRDN) reported total current assets of $784.74M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s total current assets changed year-over-year?
- Viridian Therapeutics, Inc.'s total current assets increased by 19.4% year-over-year, from $657.24M to $784.74M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s total current assets has grown at a 47.2% compound annual growth rate (CAGR), from $129.61M to $894.23M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.